Rivastigmine: the advantages of dual inhibition of acetylcholinesterase and butyrylcholinesterase and its role in subcortical vascular dementia and Parkinson’s disease dementia

Several studies have demonstrated clinical benefits of sustained cholinesterase inhibition with rivastigmine in Alzheimer’s disease (AD) and Parkinson’s disease dementia (PDD). Unlike donepezil and galantamine that selectively inhibit acetylcholinesterase (AChE; EC 3.1.1.7), rivastigmine is a unique...

Full beskrivning

Sparad:
Bibliografiska uppgifter
I publikationen:Clin Interv Aging
Huvudupphovsmän: Kandiah, Nagaendran, Pai, Ming-Chyi, Senanarong, Vorapun, Looi, Irene, Ampil, Encarnita, Park, Kyung Won, Karanam, Ananda Krishna, Christopher, Stephen
Materialtyp: Artigo
Språk:Inglês
Publicerad: Dove Medical Press 2017
Ämnen:
Review
Länkar:https://ncbi.nlm.nih.gov/pmc/articles/PMC5402908/
https://ncbi.nlm.nih.gov/pubmed/28458525
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.2147/CIA.S129145
Taggar: Lägg till en tagg
Inga taggar, Lägg till första taggen!

Liknande verk